Events

Who’s in the Room? Meet the Clinicians, Operators and Advocates Joining the London Cannabis Health Symposium

Who will you meet at Cannabis Health Symposium London next week?

Clinicians will make up just over half the audience at next week’s Cannabis Health Symposium in London, with industry professionals and investors accounting for another third.

The event at Conway Hall on 26 November will bring together experts who prescribe medical cannabis, run clinics, research treatments, and support patients. 

Alongside the talks, attendees will have time to meet colleagues, ask questions, and discuss the challenges they face in their work.

According to the booking figures as of 16 November, doctors –including consultants, GPs and psychiatrists – account for 36% of delegates.

Clinic and medical-affairs teams make up 10%, and pharmacists 5%.

Industry professionals and investors represent another 36%, followed by researchers and academics at 6%, patient advocacy organisations and professional bodies at 5%, and media at 2%.

Hearing From Doctors Already Prescribing

Not only are doctors in the audience but some will also be sharing their experience on stage, including Dr Simon Tordoff, a consultant in pain management at CB1 Medical.

Tordoff said he had no experience of prescribing medical cannabis for much of his career, but described the past four years as “a stimulating and rewarding journey”.

“I want to share with you what I’ve learned on this journey in the hope that it encourages more doctors to start prescribing cannabis in the future,” he said.

Consultant psychiatrist Dr Iain Pryde and King’s College London clinical lecturer Edward Chesney will discuss prescribing for mental health conditions, including how doctors assess who might benefit and manage concerns about dependency and psychosis.

Who Else Will Be There?

Clinic founders and researchers will also be among the speakers. David Tang, CEO and founder of CannPrescribe, will share lessons from running a medical cannabis service and preparing for Care Quality Commission inspections.

Dr Grace Blest-Hopley, founder of Hystelica, will discuss the questions women are asking about cannabis and where research still falls short.

Women deserve “proper research and products designed for their health and wellbeing, not guesswork”, she said.

They will be joined by Shanna Marrinan, director of research at 4C Labs, whose session examines what testing of illicit cannabis can tell clinicians about the risks patients face.

Hearing From Patients

Patients will also have their say, with a round-table hosted by Liam O’Dowd, editor and co-founder of leafie, on what treatment is like from their side.

O’Dowd urged clinicians and businesses to “listen carefully to the lived experiences of patients”, including where care could improve.

Alex Fraser, founder and managing director of Patient Protect, will discuss the problems patients face when employers, police and others misunderstand their right to use prescribed cannabis.

“Through Patient Protect, I see the real-world consequences of that misunderstanding regularly,” he said.

His workshop will look at what patients and the professionals supporting them can do when that happens

Who’s Supporting the Day?

Curaleaf Laboratories is the symposium’s headline partner. Other partners listed include the Medical Cannabis Clinicians Society, Drug Science, Tilray Medical x Lyphe Clinic, Retail North, PCCA UK, Dalgety, ReliefTime and leafie.

Time to Meet Beyond the Sessions

There will be time to catch up with colleagues and meet other delegates over coffee from 8.30am, and during the lunch break at 1pm.

The programme closes at 5 pm, with plans for drinks at a nearby pub afterwards. Details are still to be confirmed.

Join Us at Conway Hall

The Cannabis Health Symposium takes place at Conway Hall, London, on Thursday 26 November.

The event is CPD certified. Final-release tickets are listed at £284.09 including fees, with £100 concession tickets available to healthcare professionals by application.

View the full programme and book your place.

Jodie Yettram

Jodie Yettram

Jodie Yettram is a contributing writer at Cannabis Health, covering medical cannabis research, policy, patient access and clinical practice across the UK and Europe. An NCTJ Gold Standard, award-winning journalist from Jersey, her reporting has appeared across multiple Channel Island publications and City AM in London. She has a particular interest in women’s health, mental health and neurodiversity, having campaigned for improvements to women’s healthcare in her local paper and led an investigation into ADHD services. She also won the NCTJ’s Top Scoop award for breaking the news that Jersey’s home-birth service had been suspended.